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possible. The period for the assessment is not clearly stated. Assuming the occurrence of such behavior any time during their drinking career, it is difficult to fathom that each of 120 individuals had only one high-risk behavior. More likely, there would be multiple such behaviors in an individual subject; the recall of such events, however, could be a source of bias. Surprisingly, there is no mention of the eligibility criteria of the study participants, except for International Classification of Disease-10 criteria of alcohol dependence syndrome.
The manuscript mentions the use of "Pearson's correlation coefficient, t-test, and logistic regression" under the methods section. However, the only analysis that is reported in the original manuscript is the "chi-square test" in Tables  3 to 5 . Furthermore, the Chi-square test has been used for variables where cells are empty, which is a violation of assumption for the test. One of the assumptions states that the expected frequency in the cell should be five or more in at least 80% of the cells, and no cell should have an expected count of <1. [2] If the assumption is violated, an alternate test such as Fisher's exact test should be performed. [2] The researchers have created meaningless categories out of continuous variables such as age, age at initiation of drink, age at dependence, and duration of dependence, which limits interpretability. Specifically, such categorization leads to loss of power in detecting associations and residual confounding, hence, better avoided. [3] Multiple hypothesis testing was carried out without any corrections, which could inflate the family-wise error rate. Reporting of confidence interval could have been more meaningful.
Several other minor errors in reporting could have been avoided. For example, "P = 0.000" should be mentioned as "P < 0.001," as P value can never be zero. Uniform use of three digits after decimal points for P values and two digits after decimal points for the rest of data would enhance readability.
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Factors influencing treatment outcome in bipolar disorder

Sir,
We have read with great interest the paper titled, "Identification of factors affecting treatment outcome in bipolar disorder" by Vedanarayanan et al. [1] published recently in your journal. The article becomes timely when there is accruing research in the field of bipolar disorder (BD) course and outcome in our region. [2, 3] Identification of factors influencing treatment outcomes is a step ahead in enhancing the recovery and functioning of a patient suffering from BD.
While the paper deserves merit for incorporating a longitudinal study design in analyzing factors influencing treatment outcome, certain aspects of the paper need to be analyzed critically to replicate and expand the current research. The authors have included BD patients of various types (BD-I, BD-II, with mixed features and cyclothymia), who were in clinical remission during enrolment into the study, and assessed the improvement in clinical symptoms after 6 months from the index visit. The authors' efforts in defining early onset and treatment delay in BD were quite informative in this paper.
Although information on subtypes of BD was provided, systematic assessment of comorbid psychotic symptoms during the present mood episode and retrospective evaluation of psychiatric comorbidities seems lacking. Studies have shown that the BD tends to have frequent psychiatric comorbidities, especially anxiety disorders. [4] Mood episodes with psychotic symptoms and comorbid anxiety symptoms tend to influence poor outcomes in BD. [4] The authors have recorded the age at which BD was diagnosed albeit the age at onset (AAO) of the illness. Such data on the AAO of BD in the entire study sample (not restricted to early-onset cohort alone) would enable one to assess for the effect of AAO on treatment outcomes.
The clinical remission criteria as set by authors (Young Mania Rating Scale score [YMRS] <12) seems to be more inclusive than that recommended by the International Society for Bipolar Disorders Task Force Recommendations (YMRS <8 or <5). Hence, selection bias is quite possible. The authors have assessed for outcome after the end of the index episode. However, utilization of composite yet specific instruments such as the Clinical Global Impressions-bipolar would have ascertained the outcome for the entire illness duration and not restricting to one episode. Terms such as treatment noncompliance were assessed without definition or grades. Formats such as self-report scales and pill count are quite commonly used in BD research. [5] Under results, though the factors such as early onset and treatment delay emerged as significant predictors of poor outcome in the study sample, their wide confidence intervals warrant further repetition to validate such claims. The authors have identified that remission rates are most frequent with one group of psychotropics (lithium salts, in this study). However, information on differential compliance rates across all the psychotropic classes (lithium salts, anticonvulsants, and antipsychotics) needs to be provided before arriving at such conclusions. The discussion on bidirectional link between BD and medical comorbidities, functional recovery of BD patients, genetic underpinnings (penetrance) in BD, and reasons for noncompliance seems detached from the context of the study's objectives and observed results.
The lines on how BD leads to mental retardation (in the "introduction" part) are bound to misguide the readership. The use of an older version of diagnostic statistical manual for mental disorders, the lack of systematic inclusion or exclusion of psychiatric comorbidities, especially anxiety disorders, and the lack of systematic assessment of drug compliance are some
